Presentation is loading. Please wait.

Presentation is loading. Please wait.

Global Rapid Diagnostic Leader SD

Similar presentations


Presentation on theme: "Global Rapid Diagnostic Leader SD"— Presentation transcript:

1 Global Rapid Diagnostic Leader SD

2 Company Introduction

3 Product Line

4 Products List Rapid Tests Urine Strip & reader Hepatitis B, C
HBsAg, Anti-HBs, HCV HBeAg/HBsAg Infectious Disease HIV-1/2, Syphilis, TB, Malaria, H.pylori, Chlamydia Ag, Dengue IgG/IgM, Leprosy, Salmonella typhi, Rotavirus, Tetanus, Influenza/H5, RSV, Rubella IgG/IgM Tumor Marker AFP, CEA, PSA, CEA/AFP, FOB Drug of Abuse MOP, MET, AMP, COC, THC, MET/THC, MDMA (ecstasy) Fertility Hormone hCG, LH, FSH Veterinary Tests Heartworm, Distemper, Parvo virus, FMD Urine Strip & reader Urocolor (1~11para) Urometer 600

5 New Products Development
Present (In 2006) New Rapid Test New Patent Device Fromat Rubella IgG/IgM, Torch, Rota/Adeno, Strep A, S. pnemoniae Expanding Into NEW business fields Long term (In 2008~ ) Blood Glucose Meter DNA Chip Infectious Disease DNA Chip Congenital Disease DNA Chip Tumor DNA Chip Short term (In 2006~2007) Protein Chip Concept of Lab on a Chip Infectious Disease Panel : HIV1/2, Syphilis, HBV, TB, Malaria, HCV Tumor Markers Panel : AFP, CEA, PSA, CA19, CA125, CA15 Allergy Panel: Food Allergy, Pollen Allergy

6 Competitiveness of Technology
Market leader World-first developed products HIV ½ antibody One Step Test (three lines) 2001 SARS Anti-Coronavirus Test 2003 AIV Ag Test (including H5) for veterinary use 2004 Influenza H5 Rapid test for human use 2005 HIV1/2 1 2 C

7 Int’l Quality Approval
“Products Evaluation, Registration and Approval ” Item WHO Evaluation CE Mark USA FDA HIV1/2 Completed Under process - HCV Syphilis HBsAg Malaria hCG H.pylori Dengue Influenza Rota Urine TB

8 Sales Network “ 125 distributors in 75 Countries ”
“ 12 Domestic distributors” Sales Network in Overseas Markets Domestic Sales Network Seoul KangNung SuWon WonJu ChungJu DaeJeon DaeGu JeunJu Busan GwangJu Changwon Jeju Asia 18 countries Middle East 12 countries Europe 17 countries America/ Africa 28 countries Domestic market China, Japan, Taiwan Thailand, India, Nepal Vietnam, the Philippines Bangladesh, Sri Lanka Myanmar, Pakistan Indonesia, Malaysia Hong Kong, Mongol Australia.Singapore, … Iran, Syria, Yemen Jordan, Israel, Lebanon. Palestine Saudi Arabia,Qatar Egypt. U.A.E.Oman, Germany, Swiss, Italy Romania, Poland, Turkey, Finland, UK, Lithuania, Russia, Croatia, France, Bulgaria,Denmark, Netherlands USA, Canada ,Mexico, , Panama, Bahamas,Guyana Brazil, Colombia, Guatemala Peru, Venezuela,Paraguay, Honduras,Ecuador….. Cameron, Sudan, Nigeria Mozambique, South Africa Uganda, Kenya, Tanzania Ghana, Benin, Burkina Faso Malawi, Zimbabwe… 12 Distributors by Region

9 Influenza virus General History Diagnostic Tools AIV _ Human Infection

10 Structure of Influenza virus
HA Antigen : Help virus absorption into cells NA Antigen : help virus segregation from cells

11 Major : A (H, N) Human Infection H1N1 H3N2 H2N2 H5N1
Acute respiratory illness caused by Influenza viruses A subtype or B subtype H4 N4 H5 N5 H6 N6 H7 N7 Major : A (H, N) Human Infection H1N1 H3N2 H2N2 H5N1 H8 N8 N9 H9 H10 H11 H12 H13 H14 H15 (Karl G Nicholson, et al Lancet 2003; 362: )

12

13 Influenza Outbreak in 20th centuries
1918: “Spanish Flu” 1957: “Asian Flu” 1968: “Hong Kong Flu” 2003~4: “AIV H5” H5N1 H3N2 H2N2 H1N1 H1N1

14 Major Influenza Pandemics Period

15 “Spanish Flu” Pandemic (1918-1919)
World-wide population 2 bil. (100 %) Infected polulation bil. (20 %) Deaths mil. (1-2 %) *Outbreak in healthy young people, in the majority of cases

16 ‘Asian / HongKong Flu’ Pandemic (1957, 1968)
Killed an estimated more than 1 mil. *Outbreak in old people, or patients with chronic disease , in the majority of cases

17 Outbreak of HongKong A/H5N1 (1997)
Infection – 18 Death- 6 Protective slaughter on 1.5 mil. Chicken No infection between human

18 Outbreak of Vietnam A/H5N1 (2003~5)
Infection – 93 Death- 42

19 The Latest New Subtype Infection
1999 ; HongKong, GhuangDong _ A/H9N2 HongKong ; 2 persons infection GhuangDong 5 persons infection 2003 ; HongKong _ A/H5N1 2 persons (family) infection, 2 persons death Travel experience to Fujian 2003 ; Netherland _ A/H7N7 Infection from human to human 2003 : HongKong _ A/H9N2 1 person infection

20 Number of cases / Influenza H5/N1

21 AIV_ human Infection Mechanism (1)
Migratory birds poultry

22 AIV_ human Infection Mechanism (2)
Migratory birds poultry

23 AIV_ human Infection Mechanism (3)
Migratory birds poultry

24 Influenza Diagnostic Table
Procedure Influenza Types Detected Acceptable Specimens Time for Results Rapid result available Viral culture A and B NP swab , throat swab, nasal wash, bronchial wash, nasal aspirate, sputum 5-10 days No Immunofluorescence DFA Antibody Staining NP swab, nasal wash, bronchial wash, nasal aspirate, sputum 2-4 hours RT-PCR NP swab , throat swab, nasal wash, bronchial wash, nasal aspirate, sputum 1-2 days Serology paired acute and convalescent serum samples >2 weeks Enzyme Immuno Assay (EIA) NP swab , throat swab, nasal wash, bronchial wash 2 hours Rapid Diagnostic Tests

25 Poultry AIV – human infection Surveillance of Epidemiology case study by Korea CDC
<Step 1> Surveillance on Central Hospital around region of outbreak of AIV Review & Collection of hospitalized records Collection of blood or respiratory specimen from possible case or not-caused ARDS Laboratory diagnosis at CDC, Dept. Of infectious disease control

26 Poultry AIV – human infection Surveillance of Epidemiology case study by Korea CDC
<Step 2> If, detection of AIV_human infection possible case, you should work on enlarged surveillance with all general hospital adjacent to the region of outbreak of AIV.

27 Diagnosis of AIV infection to Human
Virus isolation in tissue culture cells, or virus inoculation into egg Viral nucleic acid : RT-PCR Hemagglutination Inhibition test (HI) Neutralization (NT) Infectious virus ELISA: recombinant antigen Western blot

28 Diagnosis of AIV infection to Human
Sample collection Description Specimen Collection time Virus isolation Respiratory specimen Early stage of onset Nucleic acid RAT (rapid antigen test) Serological Serum acute : Early stage of onset covalescent : after 3 weeks

29 First, by Rapid Antigen Testing
Diagnosis Flow chart Specimen collection Respiratory specimen Serum First, by Rapid Antigen Testing HI Participates in WHO/CDC programs for flu surveillance RT-PCR / Virus culture NT

30 Diagnostic criteria (WHO, Vietnam 2004. 1.24)
Diagnosis of AIV infection to Human Diagnostic criteria (WHO, Vietnam ) Possible Case Acute Respiratory Disease Syndrome, 38℃ high fever (and) cough (and/or) nasopharyngeal pain, Contact with A(H5N1) confirmed case during infection, or Visit at AIV outbreak poultry farm within 1 week before onset, or Person working at laboratory on research with AIV specimen

31 Diagnostic criteria (WHO, Vietnam 2004. 1.24)
Diagnosis of AIV infection to Human Diagnostic criteria (WHO, Vietnam ) Probable Case Laboratory diagnostic test results on AIV human infection _ Positive (FA +H5 mcAb analysis) Or, no cause of other respiratory disease onset Confirmed Case A(H5N1) virus isolation H5 _ PCR positive H5 _ specific antibody titer x 4  in paired acute and convalescent serum samples

32 RAT (Rapid Antigen Test)
SD BIOLINE Influenza Antigen (type A & B) SD BIOLINE Influenza H5 (A/H5N1)

33 SD BIOLINE Influenza Antigen Kit
SD BIOLINE Influenza Antigen rapid test is a chromatographic immunoassay for the differential and qualitative detection of influenza virus type A and type B antigens directly from nasal swab specimens, throat swab specimens, nasal/nasopharyngeal aspirate specimens.

34 mouse monoclonal anti-influenza A/B-gold conjugate
Test Principle & Major active ingredient - Detection by Direct Sandwich System mouse monoclonal anti-influenza A/B-gold conjugate Gold Gold Gold Flu A Ag Flu B Ag in specimen in specimen mouse monoclonal anti-influenza B mouse monoclonal anti-influenza A C line B line(Influenza B type) A line(Influenza A type) Target materials : Influenza antigen (type Aband B) in respiratory specimen

35 Test Results Appearance
Negative Influenza type A Influenza type B positive positive

36 Test procedure & Interpretation
Transfer assay diluent into test tube (approximately 300uL). Insert the patient swab sample into the test tube and mix well. Place the Test Strip into the test tube. Read result at 10 ~ 15 minutes.

37 Sample collection & Test procedure
2. Diluent 300 uL 1. Nasal swab

38 Sample collection & Test procedure
SD BIOLINE Influenza Antigen Kit Sample collection & Test procedure 4. Discard the swab. 3. Extraction

39 5. Insert test strip into tube.
SD BIOLINE Influenza Antigen Kit Sample collection & Test procedure 6. Migration 5. Insert test strip into tube.

40 Interpretation of Test Results
A/H1N A/H3N B Neg.

41 Comparison Table (Influenza RAT)
Q SD BD

42 Sensitivity per the virus type of strains
Virus types (strains) Detection Sensitivity Influenza virus,TypeA(H1N1) HN2242 (cultured sample) 0.5HAU Influenza virus,TypeA(H1N1) HN2253 (cultured sample) 0.25HAU Influenza virus,TypeA(H1N1) HN2475 (cultured sample) 0.125HAU Influenza virus, TypeA(H1N1)Taiwan/1/86 81N73 Influenza virus, TypeA(H1N1)Beijing/262/95 81N73-2 Influenza virus, TypeA(H1N1)/WS/33 VR1520(27HAU) (cultured sample) Influenza virus,TypeA(H3N2) HN30109 (cultured sample) Influenza virus,TypeA(H3N2) HN30135 (cultured sample) 0.0625HAU Influenza virus,TypeA(H3N2) HN30240 (cultured sample) Influenza virus, TypeA(H3N2)/Hongkong/8/68 VR544(26HAU) (cultured sample) Influenza virus, TypeA(H3N2)/Shangdong/9/93 81N74 Influenza virus, TypeA(H3N2)/Panama/2007/99 81N74-1 Influenza virus, TypeA(H3N2)Kiev/301/94 like/Johannesburg/33/94 81N74-2

43 Sensitivity per the virus type of strains
Virus types (strains) Detection Sensitivity Influenza virus, TypeA(H5N1)(cultured sample 210HAU) 0.2HAU Influenza virus, TypeA(H5N2)(cultured sample 25HAU) 0.05HAU Influenza virus, TypeA(H5N3)/HK/80(26~7HAU) Influenza virus,TypeA(H7N1)/Duck/Hongkong/301/78 (26HAU) 0.1HAU Influenza virus,TypeA(H9N2)/TK/WS/1/66 0.5HAU Influenza virus,TypeA(H2N2) /SINGAPORE/1/57 0.25HAU Influenza virus,TypeA(H13N6)/GULL/MALAND 0.125HAU Influenza virus,TypeA(H12N5)/DUCK/ALBERTO/60/76 Influenza virus,TypeA(H8N4) /TK/OT/6/18/68 Influenza virus,TypeA(H11N9)/DUCK/MEMPHIS/546/74 Influenza virus,TypeA(H6N5) /SHEARWATER/AUSTRALIER/1/72 0.0625HAU Influenza virus,TypeA(H10N7)/CHICKEN/GR/N/49 Influenza virus,TypeA(H4N6) /CZECH0/56 Influenza virus,TypeA(H3N6) /DUCK/UKRINE/1/63 Influenza virus,TypeB

44 Comparison data vs. RAT competitor Influenza Virus (strain)
Detection Limit of each virus type Influenza Virus (strain) Quidel BD SD Remark Type A, H1N1(2475) 1/320 1/640 Better than Quidel Equal to BD Type A, H3N2(30135) 1/1280 Type A, H5N1 1/160 1/5120 Better than Quidel, BD Type A, H5N2 1/10 Type A, H5N3 Equal to Quidel, BD Type A, H7N1 Equal to Quidel (has thick band) Less than BD Type A, H9N2 1/10240 1/20480 Equal to Quidel Type B  1/2560  1/2560

45 Clinical Evaluation Studies
The performance of the SD BIOLINE Influenza antigen test was compared to cell culture or RT-PCR methods in a multi-center field clinical study. In this multi-center, a combination of nasal swabs and throat swabs specimens were collected from total 341 patients. *Test Period ; Oct.2003 ~ May 2005 *Test Region ; Korea & Overseas Vietnam (H5) HongKong Thailand, etc

46 Clinical Evaluation Studies Summary of Clinical Evaluation Data

47 Clinical evaluation studies results performed at National Institute of Hygiene and Epidemiology, Vietnam (including H5 Human cases) *Test period : Dec.2004 ~ Dec.2005

48 SD BIOLINE Influenza Antigen test
Competitiveness of SD BIOLINE Influenza Antigen test Why should you use “SD BIOLINE Influenza Antigen Rapid Test”? SD kit can cover all influenza virus type. SD kit can detect AIV infection in Human (A/H5N1). SD kit can differentiate influenza virus type A and B SD kit is very useful as POCT (point of care testing), on-site test.

49 SD BIOLINE Influenza H5 kit
SD BIOLINE Influenza H5 rapid test is a chromatographic immunoassay for the qualitative detection of hemagglutinin H5 antigen of avian influenza (AI)virus directly from nasal swab/aspirate specimens, throat swab specimens, tracheal aspirate specimens on AI virus human infection cases.

50 mouse monoclonal anti-influenza H5-gold conjugate
Test Principle & Major active ingredient - Detection by Direct Sandwich System mouse monoclonal anti-influenza H5-gold conjugate Gold Gold Flu H5 Ag in specimen mouse monoclonal anti-influenza H5 C line T line (Influenza A/H5) Target materials : Hemagglutinin H5 antigen of avian influenza (AI) virus in respiratory specimen

51 specimen collection & preparation
Nasal swab Nasal aspirate Throat swab Tracheal aspirate (Especially, test results with the tracheal aspirate specimens would be recommendable, because the majority of AIV may exist at the tracheal position.)

52 specimen collection & preparation
If the specimen should be tested later, swab specimens should be placed into 1 ~ 2 ml of transport media or saline by direct extraction. Transport media : Use of the following transport media has been tested and found to be compatible with SD BIOLINE Influenza Antigen test. Saline EMEM+1%BSA PBS EMEM+0.5%BSA PBS+0.5%BSA Trypticase soy Broth+0.5%BSA PBS+0.5%Gelatin Trypticase soy Broth+0.5% gelatin

53 Special Precautions on Specimen collection & preparation Use of fresh sample is very important for getting accurate results. The specimen which have ever been thawed after freezing may results in decreased test sensitivity from the deterioration or modification of H5 antigen. So, repeated freezing and thawing of specimen must not be used for this test. Finally, to get accurate results, specimen should be tested as soon as possible after collection.

54 Test procedure & Interpretation
; nasal swab, throat swab Transfer assay diluent into test tube (approximately 300uL). Insert the patient swab sample into the test tube and mix well. Place the Test Strip into the test tube. Read result at 10 ~ 15 minutes.

55 Test procedure & Interpretation
; nasal aspirate, tracheal aspirate Pipet 100uL of assay diluent and 100uL of aspirate specimen into test tube. And mix well. Place the Test Strip into the test tube. Read result at 10 ~ 15 minutes.

56 Test Results Appearance ; Influenza A/H5 positive

57 SD BIOLINE Influenza H5 Limit of Detection : H5N1
(*)minimum detectable level With H5N1 (ES/03) : virus titer 27 HA unit MDL(*) 32HAU HAU HAU HAU HAU HAU

58 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen

59 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen

60 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen

61 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen Case 1 : At the WHO Collaborating Centre for Reference and Research on Influenza Dr. Aeron Hurt Address : 45 Poplar Rd,Parkville, Victoria 3052, Australia SD H5 kit could detect as below; A/Chicken/Vietnam #8 (-irradiated) – A(H5N1) – Egg grown A/Duck/Vietnam #7A (-irradiated) – A(H5N1) – Egg grown A/?/Vietnam #Pooled (-irradiated) – A(H5N1) – Egg grown Case 2 : At the Avian Section, Diagnostic Virology Laboratory National Veterinary Services Laboratories, APHIS, USDA Dr. Janice C. Pedersen, Microbiologist SD H5 kit could detect as below; TY/MN H5N2 10-1

62 Evaluation data on AIV H5 antigen
SD BIOLINE Influenza H5 Evaluation data on AIV H5 antigen Case 3 : At the ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL’EMILIA ROMAGNA “BRUNO UBERTINI” (ENTE SANITARIO DI DIRITTO PUBBLICO) Address : Via Bianchi, 9, BRESCIA, ITALY SD H5 kit could detect as below; A/ty/It/90302/05/H5N2 (LPAI) - 104,5EID50/ml as detection limit. Case 4 : At the OIE AIV Reference Laboratory Clinic for bird, reptile, amphibia and fishes Universita"t Giessen, Germany Justus-Liebig-University Giessen Frankfurter, Germany Performed by Prof. Dr. E. F. Kaleta, SD H5 kit could detect as below; H5Nx: Cell culture supernatant fluids containing H5 virus (H5N2, H5N9, H5N1) were cpe pos. in chick embryo cell cultures up to 10 to minus three.

63 Applications of Influenza Rapid kits
on Avian Influenza diagnosis programs Respiratory specimen RAT by SD BIOLINE Influenza Ag test In case of emergency that happen to outbreak of AI in the poultry, SD BIOLINE Influenza H5 test should be used directly. Type A positive Type B positive RAT by SD BIOLINE Influenza H5 test Treatment or Confirm test by RT-PCR/viral culture H5 positive negative Send Samples to Reference Laboratory that participates in WHO/CDC programs for flu/H5 surveillance, immediately Negative **WHO recommendations on the use of rapid testing for influenza diagnosis ; Influenza surveillance should be used to guide the optimal use of RAT (rapid antigen test). At the beginning of the influenza season or an influenza outbreak, RAT may influence on clinical decisions and contribute to clinical awareness.

64 Advantages as an aid of H5 diagnosis
SD BIOLINE Influenza H5 Advantages as an aid of H5 diagnosis For the screening test, the Sole H5 Avian Influenza Antigen Rapid Kit in the world Accurate detection on H5N1 samples isolated from Human infection cases, with High Sensitivity and Specificity With same kits, we’ve got lots of AI positive cases through HPAI (H5N1~H5N9) detection in the farm, market, or laboratory by use of feces or cloacal swab as veterinary use. Easy assay procedure: No technical expert and No equipment is required Labor & Time saving because of fast results

65 Global Rapid Diagnostic Leader SD
THANK YOU


Download ppt "Global Rapid Diagnostic Leader SD"

Similar presentations


Ads by Google